For the Inventor, By the Inventor

Enter assignee name

South San Francisco, CA, United States of America

Freenome Holdings, Inc.

USPTO Granted Patents = 10

EPO Patents = 1

Trademarks = 3

Forward Citations = 32

Loading Chart...

Loading Chart...

23 inventors (with patents filed for the assignee):

Adam Drake (6 out of 6 patents)

Daniel Delubac (4 out of 4 patents)

Eric Ariazi (3 out of 3 patents)

4. Gabriel Otte (2 out of 2 patents)

5. Charles Roberts (2 out of 2 patents)

6. Riley Charles Ennis (2 out of 2 patents)

7. Nathan Wan (2 out of 2 patents)

8. Tzu-Yu Liu (2 out of 2 patents)

9. Imran Haque (2 out of 2 patents)

10. Katherine Niehaus (2 out of 2 patents)

11. Ajay Kannan (2 out of 2 patents)

12. Brandon White (2 out of 2 patents)

13. John St John (2 out of 2 patents)

14. Brian D O'donovan (2 out of 2 patents)

15. John S Hawkins (1 out of 11 patents)

10 patents: Sort by Forward Citations

1. 12454724 - Methods and systems for high-depth sequencing of methylated nucleic acid (2025-10-28),

2. 12410480 - Methods and systems for detecting colorectal cancer via nucleic acid methylation analysis (2025-09-09),

3. 12372528 - Markers for the early detection of colon cell proliferative disorders (2025-07-29),

4. 12247905 - Methods and systems for sample extraction (2025-03-11),

5. 12242943 - Generating machine learning models using genetic data (2025-03-04),

6. 12228574 - Markers for the early detection of colon cell proliferative disorders (2025-02-18),

7. 11847532 - Machine learning implementation for multi-analyte assay development and testing (2023-12-19),

8. 11781959 - Methods and systems for sample extraction (2023-10-10),

9. 11681953 - Machine learning implementation for multi-analyte assay development and testing (2023-06-20),

10. 11514289 - Generating machine learning models using genetic data (2022-11-29),

Freenome Holdings, Inc. is a biotechnology company that uses advanced machine learning technology to develop non-invasive blood tests for early cancer detection. Their tests aim to revolutionize the way cancer is diagnosed and treated, providing patients with earlier and more accurate results. Freenome is committed to improving cancer outcomes through innovative technology and precision medicine.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

10 Patents

#100 in South San Francisco, CA

#6,897 in California

#29,016 in US

#54,349 in the World

South San Francisco, CA, United States of America

Freenome Holdings, Inc.

Forward Citations = 32

23 inventors:

Adam Drake (6 out of 6 patents)

Daniel Delubac (4 out of 4 patents)

Eric Ariazi (3 out of 3 patents)

4. Gabriel Otte (2 out of 2 patents)

5. Charles Roberts (2 out of 2 patents)

Please report any incorrect information to support@idiyas.com

Loading…